Clinical and Experimental Hepatology
eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
Review paper

Current approach to diagnosis and treatment of focal nodular hyperplasia in children with a management algorithm

Anna Chudoba
1, 2
,
Joanna Pawłowska
2
,
Joanna Cielecka-Kuszyk
3
,
Dorota Majak
4, 5
,
Irena Jankowska
2
,
Dorota Broniszczak-Czyszek
6
,
Jakub Barański
4
,
Piotr Czubkowski
2

  1. Clinical Department of Pediatrics and Allergology, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland
  2. Department of Gastroenterology, Hepatology, Feeding Disorders, and Pediatrics, The Children’s Memorial Health Institute, Warsaw, Poland
  3. Department od Pathology, Children’s Memorial Health Institute, Warsaw, Poland
  4. Department of Diagnostic Imaging, Children’s Memorial Health Institute, Warsaw, Poland
  5. Department of Pediatric Radiology, Medical University of Warsaw, Warsaw, Poland
  6. Department of Pediatric Surgery and Organ Transplantation, Children’s Memorial Health Institute, Warsaw, Poland
Clin Exp HEPATOL 2025; 11, 4
DOI: https://doi.org/10.5114/ceh.2025.155044
Online publish date: 2025/10/09
Article file
- Current.pdf  [0.28 MB]
Get citation
 
PlumX metrics:
 
1. Franchi-Abella S, Branchereau S. Benign hepatocellular tumors in children: Focal nodular hyperplasia and hepatocellular adenoma. Int J Hepatol 2013; 2013: 1-11.
2. Chiorean L, Cui XW, Tannapfel A, et al. Benign liver tumors in pediatric patients - Review with emphasis on imaging features. World J Gastroenterol 2015; 21: 8541-8561.
3. Zarfati A, Chambers G, Pio L, et al. Management of focal nodular hyperplasia of the liver: Experience of 50 pediatric patients in a tertiary center. J Pediatr Surg 2020; 55: 1885-1891.
4. Ng K, Mogul DB. Pediatric liver tumors. Clin Liver Dis 2018; 22: 753-772.
5. Chambers G, Zarfati A, Aderotimi T, et al. Imaging strategy for focal nodular hyperplasia in children: long-term experience from two specialist European centres. Pediatr Radiol 2023; 53: 46-56.
6. Wanless IR. The pathogenesis of focal nodular hyperplasia of the liver. J Gastroenterol Hepatol 2004; 19: 342-343.
7. Villavicencio Kim J, Wu GY. Focal nodular hyperplasia: A comprehensive review with a particular focus on pathogenesis and complications. J Clin Transl Hepatol 2024; 12: 182-190.
8. Kumagai H, Masuda T, Oikawa H, et al. Focal nodular hyperplasia of the liver: direct evidence of circulatory disturbances. J Gastroenterol Hepatol 2000; 15: 1344-1347.
9. Vilgrain V, Uzan F, Brancatelli G, et al. Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis. Radiology 2003; 229: 75-79.
10. Buscarini E, Danesino C, Plauchu H, et al. High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med Biol 2004; 30: 1089-1097.
11. Association E. Clinical Practice Guidelines EASL Clinical Practice Guidelines on the management of benign. J Hepatol 2016; 65: 386-398.
12. Scalori A, Tavani A, Gallus S, et al. Oral contraceptives and the risk of focal nodular hyperplasia of the liver: A case-control study. Am J Obstet Gynecol 2002; 186: 195-197.
13. Pasquale MD, Monti L, D’Andrea ML, et al. Focal nodular hyperplasia and hepatic regenerating nodules in pediatric oncology patients: how much invasive approach is necessary? Ann Hepatol 2013; 12: 308-314.
14. Icher-De Bouyn C, Leclere J, Raimondo G, et al. Hepatic focal nodular hyperplasia in children previously treated for a solid tumor: Incidence, risk factors, and outcome. Cancer 2003; 97: 3107-3113.
15. Ji Y, Chen S, Xiang B, et al. Clinical features of focal nodular hyperplasia of the liver in children. J Pediatr Gastroenterol Nutr 2016; 62: 813-818.
16. Towbin AJ, Luo GG, Yin H, Mo JQ. Focal nodular hyperplasia in children, adolescents, and young adults. Pediatr Radiol 2011; 41: 341-349.
17. Masetti R, Biagi C, Kleinschmidt K, et al. Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: Is hematopoietic stem cell transplantation a risk factor? Eur J Pediatr 2011; 170: 807-812.
18. Masetti R, Colecchia A, Rondelli R, et al. Benign hepatic nodular lesions after treatment for childhood cancer. J Pediatr Gastroenterol Nutr 2013; 56: 151-155.
19. Pillon M, Carucci NS, Mainardi C, et al. Focal nodular hyperplasia of the liver: An emerging complication of hematopoietic SCT in children. Bone Marrow Transplant 2015; 50: 414-419.
20. Paradis V, Laurent A, Flejou JF, et al. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology 1997; 26: 891-895.
21. Bioulac-Sage P, Rebouissou S, Sa Cunha A, et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005; 128: 1211-1218.
22. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 2008; 48: 163-170.
23. Rebouissou S, Couchy G, Libbrecht L, et al. The β-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 2008; 49: 61-71.
24. Sato Y, Harada K, Ikeda H, et al. Hepatic stellate cells are activated around central scars of focal nodular hyperplasia of the liver-a potential mechanism of central scar formation. Hum Pathol 2009; 40: 181-188.
25. Ma IT, Rojas Y, Masand PM, et al. Focal nodular hyperplasia in children: An institutional experience with review of the literature. J Pediatr Surg 2015; 50: 382-387.
26. Nasher O, Woodley H, Alizai S, et al. Hepatic benign and malignant masses in children: a single UK tertiary centre experience. Pediatr Surg Int 2022; 38: 2019-2022.
27. Lautz T, Tantemsapya N, Dzakovic A, et al. Focal nodular hyperplasia in children : clinical features and current management practice. J Pediatr Surg 2010; 45: 1797-1803.
28. Kang J, Choi HJ, Yu E, et al. A case report of fetal telangiectatic focal nodular hyperplasia. Pediatr Dev Pathol 2007; 10: 416-417.
29. Yang Y, Fu S, Li A, et al. Management and surgical treatment for focal nodular hyperplasia in children. Pediatr Surg Int 2008; 24: 699-703.
30. Al Shehri F. Focal nodular hyperplasia in children presenting as acute cholecystitis. Int J Health Sci (Qassim) 2010; 4: 194-197.
31. Tsalikidis C, Mitsala A, Pappas-Gogos G, et al. Pedunculated focal nodular hyperplasia: When in doubt, should we cut it out? J Clin Med 2023; 12: 6034.
32. Karmazyn B, Rao GS, Johnstone LS, et al. Diagnosis and follow-up of incidental liver lesions in children. J Pediatr Gastroenterol Nutr 2022; 74: 320-327.
33. Hwang SM, Yoo SY, Jeong WK, et al. Superb microvascular imaging in pediatric focal nodular hyperplasia. J Pediatr Hematol Oncol 2024; 46: e233-e240.
34. Dietrich CF, Tana C, Caraiani C, et al. Contrast enhanced ultrasound (CEUS) imaging of solid benign focal liver lesions. Expert Rev Gastroenterol Hepatol 2018; 12: 479-489.
35. Liu QY, Zhang WD, Lai DM, et al. Hepatic focal nodular hyperplasia in children: Imaging features on multi-slice computed tomography. World J Gastroenterol 2012; 18: 7048-7055.
36. Shelmerdine SC, Roebuck DJ, Towbin AJ, et al. MRI of paediatric liver tumours: How we review and report. Cancer Imaging 2016; 16: 1-10.
37. Valentino PL, Ling SC, Ng VL, et al. The role of diagnostic imaging and liver biopsy in the diagnosis of focal nodular hyperplasia in children. Liver Int 2014; 34: 227-234.
38. Oliveira C, Gil-Agostinho A, Gonçalves I, et al. Transarterial embolisation of a large focal nodular hyperplasia, using microspheres, in a paediatric patient. BMJ Case Rep 2015; 2015: bcr-2014-208879.
39. Nahm CB, Ng K, Lockie P, et al. Focal nodular hyperplasia – a review of myths and truths. J Gastrointest Surg 2011; 15: 2275-2283.
40. Gutweiler JR, Yu DC, Kim HB, et al. Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma. J Pediatr Surg 2008; 43: 2297-2300.
41. Petsas T, Tsamandas A, Tsota I, et al. A case of hepatocellular carcinoma arising within large focal nodular hyperplasia with review of the literature. World J Gastroenterol 2006; 12: 6567-6571.
42. Ortega G, Price M, Choo S, et al. Multidisciplinary management of focal nodular hyperplasia in children: Experience with 10 cases. JAMA Surg 2013; 148: 1068-1070.
43. Guérin F, Blanc T, Gauthier F, et al. Congenital portosystemic vascular malformations. YSPSU 2012; 21: 233-244.
44. Franchi-Abella S, Branchereau S, Lambert V, et al. Complications of congenital portosystemic shunts in children: Therapeutic options and outcomes. J Pediatr Gastroenterol Nutr 2010; 51: 322-330.
45. Shanmugasundaram S, Gioioso V, Martinez M, et al. Embolization of a rare case of focal nodular hyperplasia in an adolescent boy. J Pediatr Surg Case Reports 2021; 64.
46. Yan JY, Duan F, Fu JX, et al. Outcomes of transarterial embolization for large symptomatic focal nodular hyperplasia in 17 pediatric patients. Dig Liver Dis 2023; 55: 899-906.
47. Alaoui O, Mahmoudi A, Khattala K, et al. Resection of symptomatic focal nodular hyperplasia of the liver with pre-operative angioembolization. J Pediatr Surg Case Reports 2022; 84: 102383.
48. Perrakis A, Vassos N, Grützmann R, et al. What is changing in indications and treatment of focal nodular hyperplasia of the liver: Is there any place for surgery? Ann Hepatol 2019; 16: 333-341.
49. Alnajjar A, Al Sebayel M, Elsiesy H. Liver transplantation for Budd-Chiari syndrome with large solitary focal nodular hyperplasia of the liver in a patient with essential thrombocytemia: case report. Transplant Proc 2015; 47: 2282-2286.
50. Kochin IN, Miloh TA, Arnon R, et al. Benign liver masses and lesions in children: 53 cases over 12 years. Isr Med Assoc J 2011; 13: 542-547.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.